Insider · CIK 0001543792
Matthew L. Posard
Files at HALO (HALOZYME THERAPEUTICS, INC.), NAUT (Nautilus Biotechnology, Inc.). First filing Sep 17, 2026, latest Oct 2, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HALO: HALOZYME THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | HALOZYME THERAPEUTICS, INC. | $568k 5,230 shares | -9% | +74% from low-7% from high | |
| 33Weak | HALOZYME THERAPEUTICS, INC. | $2.0M 18,996 shares | -24% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -730 | $107.17 | $78k | 58,109 | 10 d ago |
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,300 | $108.45 | $358k | 54,809 | 10 d ago |
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -1,100 | $109.57 | $121k | 53,709 | 10 d ago |
| Oct 1, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $110.04 | $11k | 53,609 | 10 d ago |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,100 | $106.13 | $329k | 74,735 | 25 d ago |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -3,000 | $106.83 | $320k | 71,735 | 25 d ago |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -8,896 | $108.04 | $961k | 62,839 | 25 d ago |
| Sep 16, 2026 | HALO HALOZYME THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -4,000 | $108.99 | $436k | 58,839 | 25 d ago |
| Jun 23, 2025 | NAUT Nautilus Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jun 25, 2025 |
| May 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Common Stock | +4,165 | $0.00 | $0 | 74,039 | May 2, 2025 |
| May 1, 2025 | HALO HALOZYME THERAPEUTICS, INC. | AGrant or award Option to Purchase Common Stockderivative | +5,750 | $0.00 | $0 | 5,750 | May 2, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.